Burundi vs Cyprus: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Burundi
0.4%
in 2024
Cyprus
0.5%
in 2024
Burundi rank
59th
Cyprus rank
56th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Burundi
- Cyprus
How they compare
Cyprus currently reports 0.5% against 0.4% in Burundi, a difference of 0.1%.
That makes Cyprus's figure about 1.2 times Burundi's.
Across all 10 years both countries report, Cyprus has been ahead every year.
Burundi ranks 59th and Cyprus ranks 56th of 215 countries.
Cyprus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burundi | Cyprus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.6% | 0.2% | Cyprus |
| 2020s | 0.4% | 0.5% | 0.1% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Burundi or Cyprus?
- Cyprus, at 0.5% against 0.4% in Burundi as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Burundi and Cyprus?
- 0.1%, with Cyprus ahead.
- How many years of comparable data are there for Burundi and Cyprus?
- 10 years are reported by both, from 2015 to 2024.
- How do Burundi and Cyprus rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Burundi ranks 59th and Cyprus ranks 56th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.